David M Stack's most recent trade in Pacira BioSciences Inc was a trade of 245,400 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 14, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 245,400 | 245,400 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 32,700 | 186,481 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 37.87 per share. | 06 Jun 2023 | 5,326 | 153,781 (0%) | 0% | 37.9 | 201,669 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 38.99 per share. | 06 Jun 2023 | 5,058 | 159,107 (0%) | 0% | 39.0 | 197,216 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 160,900 | 160,900 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 21,500 | 163,751 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 61.37 per share. | 06 Jun 2022 | 11,965 | 156,079 (0%) | 0% | 61.4 | 734,340 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 59.10 per share. | 06 Jun 2022 | 7,039 | 149,040 (0%) | 0% | 59.1 | 416,005 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 60.33 per share. | 06 Jun 2022 | 5,006 | 144,034 (0%) | 0% | 60.3 | 302,012 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 61.31 per share. | 06 Jun 2022 | 1,282 | 142,752 (0%) | 0% | 61.3 | 78,599 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 61.96 per share. | 06 Jun 2022 | 501 | 142,251 (0%) | 0% | 62.0 | 31,042 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 22,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.81 per share. | 28 Apr 2022 | 22,500 | 168,044 (0%) | 0% | 10.8 | 243,225 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.81 per share. | 31 Mar 2022 | 22,500 | 145,544 (0%) | 0% | 10.8 | 243,225 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2022 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.81 per share. | 25 Jan 2022 | 13,670 | 123,044 (0%) | 0% | 10.8 | 147,773 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2022 | 13,670 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.81 per share. | 11 Jan 2022 | 15,000 | 109,374 (0%) | 0% | 10.8 | 162,150 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2022 | 15,000 | 58,670 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.81 per share. | 16 Nov 2021 | 15,000 | 94,085 (0%) | 0% | 10.8 | 162,150 | Common Stock |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2021 | 15,000 | 73,670 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | David M. Stack | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 61.04 per share. | 04 Jun 2021 | 14,905 | 61,156 (0%) | 0% | 61.0 | 909,756 | Common Stock |